Terms: = Colorectal cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF
181 results:
1. Understanding colorectal cancer Patient Experiences with Family Practitioners in Canada.
Mksyartinian P; Mohammad N; Wildgoose P; Stein BD
Curr Oncol; 2024 May; 31(6):3122-3148. PubMed ID: 38920721
[TBL] [Abstract] [Full Text] [Related]
2. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study).
Kinos S; Hagman H; Halonen P; Soveri LM; O'Reilly M; Pfeiffer P; Frödin JE; Sorbye H; Heervä E; Liposits G; Kallio R; Ålgars A; Ristamäki R; Salminen T; Bärlund M; Shah CH; McDermott R; Röckert R; Flygare P; Kwakman J; Teske A; Punt C; Glimelius B; Österlund P
Acta Oncol; 2024 May; 63():248-258. PubMed ID: 38698698
[TBL] [Abstract] [Full Text] [Related]
3. Evaluating false-positive detection in a computer-aided detection system for colonoscopy.
Okumura T; Imai K; Misawa M; Kudo SE; Hotta K; Ito S; Kishida Y; Takada K; Kawata N; Maeda Y; Yoshida M; Yamamoto Y; Minamide T; Ishiwatari H; Sato J; Matsubayashi H; Ono H
J Gastroenterol Hepatol; 2024 May; 39(5):927-934. PubMed ID: 38273460
[TBL] [Abstract] [Full Text] [Related]
4. Effect of gender discordance on surgical outcomes in predominantly female patient surgeries in NYS.
Smolkin C; Zhang X; Sethi I; Torres A; Yang J; Spaniolas K; Pryor AD
Surg Endosc; 2024 Mar; 38(3):1556-1567. PubMed ID: 38151678
[TBL] [Abstract] [Full Text] [Related]
5. Screening and validation of the optimal panel of reference genes in colonic epithelium and relative cancer cell lines.
Hu Y; Jiang Q; Zhai X; Liu L; Hong Y
Sci Rep; 2023 Oct; 13(1):17777. PubMed ID: 37853035
[TBL] [Abstract] [Full Text] [Related]
6. Fertility preservation in reproductive-aged female patients with colorectal cancer: a scoping review.
Landay SL; Burns JA; Bickle ML; Baltich Nelson B; Nipp RD
Support Care Cancer; 2023 Oct; 31(10):612. PubMed ID: 37796328
[TBL] [Abstract] [Full Text] [Related]
7. Selective prediction for extracting unstructured clinical data.
Swaminathan A; Lopez I; Wang W; Srivastava U; Tran E; Bhargava-Shah A; Wu JY; Ren AL; Caoili K; Bui B; Alkhani L; Lee S; Mohit N; Seo N; Macedo N; Cheng W; Liu C; Thomas R; Chen JH; Gevaert O
J Am Med Inform Assoc; 2023 Dec; 31(1):188-197. PubMed ID: 37769323
[TBL] [Abstract] [Full Text] [Related]
8. Real-World Treatment Sequencing in Vulnerable Patients with Metastatic colorectal cancer: A Multicenter Retrospective Study.
Mitani S; Kito Y; Hino K; Kawakami K; Izawa N; Hanamura F; Yamamoto Y; Shoji H; Komori A; Boku S; Tsuchihashi K; Kato K; Nonagase Y; Matsumoto T; Furuta M; Kawakami H
Target Oncol; 2023 Sep; 18(5):707-715. PubMed ID: 37668815
[TBL] [Abstract] [Full Text] [Related]
9. Fovea-UNet: detection and segmentation of lymph node metastases in colorectal cancer with deep learning.
Liu Y; Wang J; Wu C; Liu L; Zhang Z; Yu H
Biomed Eng Online; 2023 Jul; 22(1):74. PubMed ID: 37479991
[TBL] [Abstract] [Full Text] [Related]
10. The effect of numeric information about the likelihood of receiving a false negative or false positive result on people's attitudes towards colorectal cancer screening using faecal immunochemical testing (FIT).
Miles A; Paschalidi A; Sharma N
Patient Educ Couns; 2023 Sep; 114():107857. PubMed ID: 37348310
[TBL] [Abstract] [Full Text] [Related]
11. The effect of mechanical bowel preparation on postoperative complications in laparoscopic right colectomy: a retrospective propensity score matching analysis.
Perets M; Yellinek S; Carmel O; Boaz E; Dagan A; Horesh N; Reissman P; Freund MR
Int J Colorectal Dis; 2023 May; 38(1):133. PubMed ID: 37193834
[TBL] [Abstract] [Full Text] [Related]
12. Maintenance therapy with Fluoropyrimidine and cetuximab or bevacizumab after first line FOLFOX-chemotherapy in metastatic colorectal cancer according to RAS or BRAF
Kang S; Lee MW; Song IC; Lee HJ; Yun HJ; Jo DY; Kim JS; Kwon JH; Kim JY; Lee KH; Ryu H
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7819-7829. PubMed ID: 37031435
[TBL] [Abstract] [Full Text] [Related]
13. Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer.
Punt CJA; Heinemann V; Maughan T; Cremolini C; Van Cutsem E; McDermott R; Bodoky G; André T; Osterlund P; Teske AJ; Pfeiffer P
ESMO Open; 2023 Apr; 8(2):101199. PubMed ID: 37018874
[TBL] [Abstract] [Full Text] [Related]
14. Can frailty scores predict the incidence of cancer? Results from two large population-based studies.
Mak JKL; Kuja-Halkola R; Wang Y; Hägg S; Jylhävä J
Geroscience; 2023 Jun; 45(3):2051-2064. PubMed ID: 36997701
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
[TBL] [Abstract] [Full Text] [Related]
16. Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT).
Lombardi P; Aimar G; Peraldo-Neia C; Bonzano A; Depetris I; Fenocchio E; Filippi R; Quarà V; Milanesio M; Cavalloni G; Gammaitoni L; Basiricò M; Cagnazzo C; Ostano P; Chiorino G; Aglietta M; Leone F
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562382
[TBL] [Abstract] [Full Text] [Related]
17. Different neoadjuvant therapies for locally advanced rectal cancer: A systematic review and network meta-analysis.
Petrelli F; Trevisan F; Tomasello G; De Stefani A; Viti M; Garrone O; Luciani A; Ghidini M
Crit Rev Oncol Hematol; 2022 Dec; 180():103853. PubMed ID: 36252747
[TBL] [Abstract] [Full Text] [Related]
18. Residence near industrial complex and cancer incidence: A registry-based cohort of 1,022,637 participants with a follow-up of 21 years, Israel.
Kayyal-Tarabeia I; Blank M; Zick A; Agay-Shay K
Environ Res; 2023 Jan; 216(Pt 1):114471. PubMed ID: 36208787
[TBL] [Abstract] [Full Text] [Related]
19. Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression.
Chen S; Li X; Li Y; Yuan X; Geng C; Gao S; Li J; Ma B; Wang Z; Lu W; Hu HG
Theranostics; 2022; 12(15):6665-6681. PubMed ID: 36185610
[No Abstract] [Full Text] [Related]
20. MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAF
Tabernero J; Grothey A; Arnold D; de Gramont A; Ducreux M; O'Dwyer P; Tahiri A; Gilberg F; Irahara N; Schmoll HJ; Van Cutsem E
ESMO Open; 2022 Oct; 7(5):100559. PubMed ID: 36029653
[TBL] [Abstract] [Full Text] [Related]
[Next]
